Staging cardiac damage associated with aortic stenosis in patients undergoing transcatheter aortic valve implantation.

Okuno, Taishi; Heg, Dik; Lanz, Jonas; Stortecky, Stefan; Praz, Fabien; Windecker, Stephan; Pilgrim, Thomas (2021). Staging cardiac damage associated with aortic stenosis in patients undergoing transcatheter aortic valve implantation. International Journal of Cardiology. Heart & Vasculature, 33, p. 100768. Elsevier 10.1016/j.ijcha.2021.100768

Okuno_IntJCardiolHeartVasc_2021.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (707kB) | Preview


A new staging classification of aortic stenosis (AS) characterizing the extent of cardiac damage was established and validated in patients undergoing transcatheter aortic valve implantation (TAVI). The present study was aimed to refine the staging system by integrating a quantitative evaluation of right ventricular (RV) dysfunction defined by current echocardiographic guideline recommendations.

Methods and results

In a prospective TAVI registry, patients were categorized into the stages: no cardiac damage (Stage 0), left ventricular damage (Stage 1), left atrial or mitral valve damage (Stage 2), pulmonary vasculature or tricuspid valve damage (Stage 3), or RV damage (Stage 4) based on baseline echocardiography. Among 1133 eligible patients undergoing TAVI, 8 (3.4%) patients were categorized as Stage 0, 113 (10.0%) as Stage 1, 397 (35.0%) as Stage 2, 239 (21.1%) as Stage 3, and 346 (30.5%) as Stage 4. There was a stepwise increase in all-cause and cardiovascular mortality rates at 1 year according to increasing stages of secondary cardiac damage: 5.4% and 0% in Stage 0, 5.3% and 1.8% in Stage 1, 8.9% and 5.9% in Stage 2, 17.7% and 12.9% in Stage 3, and 25.8% and 19.9% in Stage 4, respectively. After multivariable adjustment, increasing stages of cardiac damage gradually correlated with all-cause and cardiovascular mortality.


A significant number of patients with AS underwent TAVI only once cardiac damage has already occurred. Integrating a guideline-based definition of RV dysfunction increased the sensitivity of the staging system to identify patients at increased risk of death after TAVI.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology
04 Faculty of Medicine > Pre-clinic Human Medicine > Department of Clinical Research (DCR)

UniBE Contributor:

Okuno, Taishi, Heg, Dierik Hans, Lanz, Jonas, Stortecky, Stefan, Praz, Fabien Daniel, Windecker, Stephan, Pilgrim, Thomas


600 Technology > 610 Medicine & health








Andrea Flükiger-Flückiger

Date Deposited:

07 May 2021 10:42

Last Modified:

20 Feb 2024 14:16

Publisher DOI:


PubMed ID:


Uncontrolled Keywords:

Aortic stenosis Cardiac damage Prognosis Staging Transcatheter aortic valve implantation




Actions (login required)

Edit item Edit item
Provide Feedback